abstract |
A novel benzoxazolinone derivative represented by the formula (1). [1] Also provided is a novel therapeutic agent for Parkinson's diseases which has a high bonding affinity for and high agonistic activity against both a dopamine D2 receptor and a serotonin 5-HT1A receptor. |